Skip to main content
Clinical Trials/NCT01041872
NCT01041872
Completed
Phase 4

Dose-effect of Propofol for Anesthetic Induction: Double-blind Comparison of Different Propofol Formulations Administered Alone or With Lidocaine

Hopital Foch3 sites in 1 country212 target enrollmentDecember 2009

Overview

Phase
Phase 4
Intervention
Propofol Astrazeneca plain
Conditions
General Anesthesia
Sponsor
Hopital Foch
Enrollment
212
Locations
3
Primary Endpoint
necessary dose of propofol to obtain the induction of anesthesia (defined by a bispectral index of 50)
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The objective of this study is to evaluate the influence of different propofol formulations(plain or with lidocaine)on anesthetic induction. Propofol plain or with lidocaine is administered using a closed-loop algorithm in order to reach a Bispectral Index target of 50.

Registry
clinicaltrials.gov
Start Date
December 2009
End Date
July 2011
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • patients scheduled for an intravenous induction of anesthesia with propofol

Exclusion Criteria

  • Age under 18
  • Pregnancy or breastfeeding
  • Allergy to propofol, soya or peanuts,
  • Allergy to lidocaine,
  • History of central neurological disorder or brain injury,
  • Patients receiving psychotropic drugs,
  • Patient with a pacemaker.

Arms & Interventions

Propofol Astrazeneca

Propofol with saline is administered using a closed-loop algorithm which permits to reach a Bispectral Index target of 50. The blinded syringe contains 45 ml of propofol and 5 ml of saline.

Intervention: Propofol Astrazeneca plain

Propofol Astrazeneca plus lidocaine

Propofol with lidocaine 1¨% is administered using a closed-loop algorithm which permits to reach a Bispectral Index target of 50. The blinded syringe contains 45 ml of propofol and 5 ml of lidocaine.

Intervention: Propofol Astrazeneca plus lidocaine

Propofol-lipuro B. Braun plain

Propofol with saline is administered using a closed-loop algorithm which permits to reach a Bispectral Index target of 50. The blinded syringe contains 45 ml of propofol and 5 ml of saline.

Intervention: Propofol-lipuro B. Braun plain

Propofol-lipuro B. Braun plus lidocaine

Propofol with lidocaine 1¨% is administered using a closed-loop algorithm which permits to reach a Bispectral Index target of 50. The blinded syringe contains 45 ml of propofol and 5 ml of lidocaine.

Intervention: Propofol-lipuro B. Braun plus lidocaine

Propofol Fresenius plain

Propofol with saline is administered using a closed-loop algorithm which permits to reach a Bispectral Index target of 50. The blinded syringe contains 45 ml of propofol and 5 ml of saline.

Intervention: Propofol Fresenius plain

Propofol Fresenius plus lidocaine

Propofol with lidocaine 1¨% is administered using a closed-loop algorithm which permits to reach a Bispectral Index target of 50. The blinded syringe contains 45 ml of propofol and 5 ml of lidocaine.

Intervention: Propofol Fresenius plus lidocaine

Outcomes

Primary Outcomes

necessary dose of propofol to obtain the induction of anesthesia (defined by a bispectral index of 50)

Time Frame: end of anesthetic induction

Secondary Outcomes

  • calculated concentrations of propofol at the end of the anesthetic induction(end of the anesthetic induction)
  • measured plasma propofol concentrations at the end of anesthetic induction (in 20% of patients)(3 months after the end of patient's recruitment)
  • pain at injection(during the PACU (post-anaesthesia care unit) stay)
  • heart rate and arterial pressure modifications induced by anesthetic induction(end of anesthetic induction)
  • patients satisfaction(during the PACU stay)
  • necessary dose of propofol to obtain loss of consciousness(end of anesthetic induction)
  • calculated concentrations of propofol at loss of consciousness(end of anesthetic induction)

Study Sites (3)

Loading locations...

Similar Trials